Depletion of MSI2 in NSCLC cells significantly decreased cell invasion and metastasis via TGF-β signaling [17], and potentiated chemotherapy response to EGFR inhibitors in EGFR-mutated NSCLC cells [18]. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.